middl
east
respiratori
syndrom
mer
lethal
zoonosi
caus
mer
coronaviru
merscov
pose
signific
threat
public
health
worldwid
therefor
rapid
sensit
specif
serolog
test
detect
antimerscov
antibodi
human
anim
urgent
need
success
manag
ill
evalu
variou
novel
luciferas
immunosorb
assay
lisa
base
nucleocapsid
protein
np
well
fragment
deriv
spike
protein
includ
subunit
n
termin
domain
ntd
receptorbind
domain
rbd
subunit
detect
merscovspecif
igg
fusion
protein
includ
nanoluciferas
nluc
variou
fragment
deriv
np
protein
merscov
express
human
embryon
kidney
cell
lisa
detect
antimerscov
igg
develop
use
cell
lysat
express
variou
fusion
protein
panel
human
anim
sampl
infect
merscov
use
analyz
sensit
specif
variou
lisa
refer
merscov
rtpcr
commerci
elisa
pseudoviru
particl
neutral
test
ppnt
result
show
rbd
nplisa
sensit
ntdand
detect
antimerscov
igg
furthermor
rbd
nplisa
sensit
least
commerci
avail
moreov
rbd
nplisa
specif
recogn
antimerscov
igg
crossreact
sampl
deriv
human
cov
infect
patient
importantli
lisa
prove
applic
reliabl
detect
antimerscov
igg
sampl
camel
monkey
mice
among
rbdlisa
exhibit
excel
perform
result
studi
suggest
novel
merscov
rbdand
highli
effect
platform
rapid
sensit
detect
antimerscov
igg
human
anim
sampl
assay
potenti
use
serolog
test
manag
control
merscov
infect
middl
east
respiratori
syndrom
mer
lethal
zoonosi
caus
mer
coronaviru
cov
merscov
infect
human
caus
asymptomat
mild
respiratori
ill
sever
pneumonia
multiorgan
failur
even
death
accord
world
health
organ
may
laboratoryconfirm
case
mer
death
casefat
rate
report
countri
http
major
mer
case
occur
middl
east
especi
saudi
arabia
date
confirm
mer
case
link
middl
east
humantohuman
transmiss
merscov
well
document
famili
commun
healthcar
set
merscov
pose
signific
threat
public
health
worldwid
high
fatal
rate
mer
infect
potenti
outbreak
merscov
infect
healthcar
facil
furthermor
specif
vaccin
therapeut
prevent
treatment
merscov
infect
dromedari
camel
implic
zoonot
sourc
human
infect
merscov
rna
viabl
viru
isol
seropreval
merscov
antibodi
high
dromedari
camel
within
eastern
africa
arabian
peninsula
continu
mer
epidem
middl
east
believ
relat
failur
control
zoonot
sourc
particularli
dromedari
camel
result
ongo
cameltohuman
transmiss
moreov
merslik
cov
detect
bat
speci
global
thu
thought
reservoir
merscov
howev
exact
sourc
mani
primari
mer
case
remain
unknown
transmiss
mechan
poorli
understood
merscov
genom
encod
nonstructur
protein
four
structur
protein
includ
spike
small
envelop
e
membran
nucleocapsid
n
protein
viral
structur
protein
n
highest
immunogen
protein
undergo
proteas
cleavag
subunit
subunit
mediat
coronaviru
entri
host
cell
bind
receptor
hostcel
surfac
via
receptorbind
domain
rbd
subunit
n
protein
major
immunodomin
region
merscov
often
appli
target
antigen
detect
humor
immun
respons
infect
realtim
quantit
revers
transcriptionpolymeras
chain
reaction
qrtpcr
common
method
diagnosi
merscov
infect
howev
suitabl
detect
infect
clinic
unit
largescal
epidemiolog
screen
specif
antibodi
play
import
role
determin
sever
human
infect
detect
specif
antibodi
use
epidemiolog
investig
merscov
infect
anim
human
sever
method
use
detect
serum
antibodi
merscov
enzymelink
immunosorb
assay
elisa
microneutr
mn
immunofluoresc
assay
ifa
plaqu
reduct
neutral
test
prnt
pseudoviru
particl
neutral
test
ppnt
among
assay
mn
ifa
prnt
depend
viru
cultiv
thu
requir
equip
facil
locat
within
biosafeti
level
laboratori
commerci
antimerscov
serolog
test
kit
human
anim
includ
elisa
ifa
rapid
sensit
serolog
assay
detect
antimerscov
igg
independ
purifi
protein
specif
secondari
antibodi
viru
cultiv
facil
still
urgent
need
ultrasensit
highthroughput
luciferas
immunosorb
assay
lisa
base
recombin
antigen
fuse
nanoluc
luciferas
nluc
report
detect
igg
sever
pathogen
assay
advantag
requir
laboratori
facil
speciesspecif
label
secondari
antibodi
detect
studi
develop
variou
novel
lisa
platform
base
merscov
np
fragment
diagnost
perform
variou
merscov
lisa
evalu
use
serum
panel
merscovinfect
human
anim
well
sera
patient
infect
human
cov
sever
panel
antimerscov
igg
detect
collect
store
test
detail
inform
describ
studi
evalu
novel
luciferas
immunosorb
assay
lisa
base
nucleocapsid
protein
np
well
fragment
deriv
spike
protein
detect
merscovspecif
igg
human
anim
evid
studi
enzymelink
immunosorb
assay
elisa
microneutr
mn
immunofluoresc
assay
ifa
pseudoviru
particl
neutral
test
ppnt
perform
detect
serum
antibodi
merscov
remain
need
develop
novel
serolog
assay
independ
protein
purif
special
secondari
antibodi
viru
cultiv
biosafeti
level
laboratori
studi
novel
lisa
base
merscov
fragment
np
develop
human
anim
sampl
infect
merscov
measur
newli
develop
lisa
well
refer
method
includ
commerci
ppnt
result
show
rbd
nplisa
abl
specif
distinguish
merscovinfect
sampl
sampl
infect
hcov
consist
refer
method
compar
commerci
avail
rbdlisa
sensit
moreov
applic
reliabl
lisa
verifi
detect
antimerscov
igg
sampl
camel
monkey
mice
rbdlisa
exhibit
superior
sensit
specif
novel
merscov
rbdand
develop
independ
protein
purif
special
secondari
antibodi
show
super
specif
effici
detect
antimerscov
igg
human
anim
sampl
assay
recommend
serolog
diagnosi
merscov
infect
investig
epidem
characterist
origin
trace
vaccin
studi
merscov
would
contribut
scientif
control
prevent
mer
tabl
brief
panel
includ
follow
normal
serum
sampl
healthi
blood
donor
without
merscov
infect
store
laboratori
convalesc
sera
five
merscov
infect
patient
sera
five
merscov
patient
high
antibodi
titer
sera
five
merscov
patient
medium
titer
mix
prepar
two
pool
convalesc
serum
sampl
control
sera
seven
nonmerscov
patient
individu
antibodi
common
human
cov
hcov
name
suppli
serum
sampl
confirm
merscovinfect
camel
saudi
arabia
suppli
univers
hong
kong
serum
sampl
merscovinfect
monkey
mice
store
laboratori
besid
sampl
list
tabl
one
convalesc
serum
sampl
first
import
merscovinfect
patient
china
also
detect
studi
character
lisa
present
studi
approv
institut
review
board
nation
institut
viral
diseas
control
prevent
china
cdc
ethic
committe
southern
medic
univers
smu
shown
figur
merscov
np
aa
fragment
merscov
ntermin
domain
ntd
aa
rbd
aa
aa
amplifi
rtpcr
gene
fragment
clone
luciferas
express
vector
promega
madison
wi
usa
recombin
plasmid
confirm
dna
sequenc
human
embryon
kidney
hek
cell
seed
cell
cultur
plate
cultur
confluenc
reach
recombin
plasmid
transfect
hek
cell
use
transfect
reagent
polyplu
illkirch
franc
accord
manufactur
instruct
h
cell
lyse
ice
min
lysat
buffer
supernat
harvest
centrifug
rpm
min
express
np
fragment
fusion
protein
verifi
sodium
dodecyl
sulfatepolyacrylamid
gel
electrophoresi
sdspage
western
blot
wb
nluc
activ
supernat
detect
react
luciferas
substrat
mix
promega
rel
fluoresc
intens
rfi
valu
immedi
determin
use
gaomax
luminomet
promega
briefli
costar
flatbottom
luminometri
plate
coat
protein
g
carbon
buffer
ph
overnight
three
wash
phosphatebuff
salin
pb
contain
tween
pbst
plate
incub
block
solut
pb
contain
nonfat
milk
h
well
wash
aliquot
serial
dilut
sera
ad
well
incub
h
plate
wash
incub
dilut
nlucfus
protein
min
plate
wash
luciferas
substrat
promega
ad
well
rfi
valu
determin
use
gaomax
luminomet
promega
sampl
test
duplic
cutoff
valu
determin
twofold
averag
normal
control
neg
control
equal
volum
mixtur
sera
healthi
blood
donor
result
express
mean
rfi
duplic
well
valu
correct
subtract
rfi
valu
background
well
incub
hek
cell
extract
absenc
sera
detect
merscovspecif
nucleic
acid
sampl
perform
use
qrtpcr
target
gene
upstream
envelop
upe
np
n
previous
report
commerci
avail
antimerscov
elisa
igg
kit
base
purifi
merscov
spike
protein
domain
elisa
euroimmun
germani
sampl
serial
dilut
test
accord
manufactur
recommend
euroimmun
recommend
interpret
result
semiquantit
way
follow
ratio
extinct
control
patient
sampl
extinct
calibr
defin
neg
borderlin
posit
respect
merscov
sbase
ppnt
use
detect
neutral
activ
serum
sampl
previous
report
detect
result
express
rli
serum
neutral
antibodi
activ
evalu
pseudoviru
inhibit
rate
inhibit
rate
rli
normal
control
rli
sampl
rli
normal
control
inhibit
rate
character
posit
neutral
activ
data
analyz
use
graphpad
prism
graphpad
softwar
inc
la
jolla
ca
usa
spss
ibm
new
york
ny
usa
pearson
correl
coeffici
among
differ
assay
calcul
statist
signific
defin
p
valu
establish
novel
detect
method
merscov
igg
five
recombin
plasmid
base
nluc
construct
separ
contain
fulllength
merscov
np
ntd
rbd
figur
plasmid
confirm
restrict
endonucleas
digest
gel
electrophoresi
dna
sequenc
recombin
plasmid
use
transfect
hek
cell
express
target
protein
supernat
cell
lysat
determin
wb
use
murin
polyclon
antibodi
merscov
figur
result
confirm
construct
recombin
plasmid
express
target
fusion
protein
merscov
np
ntd
rbd
protein
figur
use
develop
lisa
character
bind
domain
need
antimerscov
igg
order
avoid
differ
transfect
effici
protein
express
differ
prepar
measur
luciferas
activ
crude
cell
lysat
determin
rfi
usual
individu
antigen
cell
lysat
minimum
rfi
ad
reaction
lisa
addit
includ
posit
neg
control
reaction
plate
ensur
result
consist
reproduc
normal
neg
control
serum
sampl
healthi
blood
donor
dilut
use
determin
background
valu
calcul
cutoff
level
anti
merscov
igg
detect
lisa
cutoff
valu
determin
averag
rfi
valu
normal
adult
control
ie
rbd
np
ntd
merscov
igg
respect
serum
sampl
first
import
figur
merscovinfect
patient
china
serial
dilut
detect
rbdlisa
confirm
posit
sampl
dilut
low
slightli
better
nplisa
howev
ntdlisa
unabl
distinguish
posit
sampl
normal
control
dilut
abl
detect
differ
dilut
figur
indic
rbd
nplisa
superior
ntdand
detect
mrescov
igg
human
sampl
confirm
effici
rbd
nplisa
panel
sampl
suppli
tabl
use
compar
efficaci
variou
lisa
detect
antimerscov
igg
togeth
commerci
avail
euroimmun
ppnt
kit
control
result
summar
tabl
illustr
figur
np
rbdlisa
show
high
consist
ppnt
method
abl
specif
distinguish
merscovinfect
sampl
hcovinfect
sampl
tabl
figur
subsequ
correl
rbd
npbase
lisa
base
analyz
figur
scatter
plot
show
excel
correl
rbd
nplisa
pearson
correl
coeffici
respect
evalu
sensit
rbd
nplisa
sever
serum
sampl
suppli
dilut
serial
detect
assay
figur
rbdlisa
confirm
posit
sampl
confirm
two
four
volum
fifth
serum
enough
detect
dilut
low
rbdlisa
highli
superior
np
detect
sampl
posit
dilut
howev
four
posit
sampl
detect
even
dilut
indic
lower
limit
detect
merscov
lisa
tabl
fold
higher
moreov
receiv
oper
characterist
roc
analysi
conduct
determin
sensit
specif
rbd
nplisa
figur
serum
dilut
area
curv
auc
calcul
four
assay
percentag
sensit
specif
assay
estim
given
cutoff
valu
serum
dilut
even
auc
rbdlisa
calcul
auc
nplisa
declin
slightli
respect
addit
percentag
sensit
specif
rbdlisa
maintain
given
cutoff
valu
howev
sensit
figur
correl
merscov
lisa
rfi
ratio
detect
igg
antibodi
ratio
result
plot
rfi
rbdlisa
nplisa
sampl
use
plot
includ
five
convalesc
serum
sampl
merscovinfect
patient
multipl
dilut
three
sera
normal
neg
control
list
tabl
figur
analysi
sensit
merscov
lisa
five
sampl
four
convalesc
sera
merscovinfect
patient
one
normal
serum
use
neg
control
volum
fifth
convalesc
serum
enough
detect
serial
dilut
dispens
well
plate
sampl
test
duplic
data
repres
least
two
independ
experi
nplisa
declin
respect
even
though
specif
still
result
indic
rbdlisa
superior
nplisa
sensit
specif
detect
antimerscov
antibodi
human
serum
sampl
evalu
effici
merscovlisa
serum
sampl
uninfect
camel
control
merscovinfect
camel
confirm
posit
rtpcr
monkey
mice
detect
use
figur
roc
analysi
auc
valu
antibodi
panel
determin
use
dilut
left
dilut
right
use
commerci
euroimmun
inhous
b
rbdlisa
c
nplisa
abovement
lisa
ppnt
control
result
shown
tabl
normal
camel
sampl
confirm
neg
method
test
total
merscovinfect
camel
sampl
posit
ppnt
neg
inconsist
rtpcr
result
notabl
posit
antimerscov
igg
base
rbd
nplisa
detect
posit
ppnt
neg
antimerscov
igg
base
rbd
nplisa
moreov
sampl
determin
posit
ppnt
rbdlisa
neg
nplisa
result
also
show
two
sampl
merscovinfect
marmoset
monkey
two
sampl
merscov
infect
mice
posit
via
ppnt
well
rbd
nplisa
result
show
rtpcr
result
serv
standard
sensit
rbd
nplisa
respect
specif
assay
ppnt
result
serv
standard
sensit
respect
specif
assay
result
show
rbd
nplisa
highli
consist
ppnt
result
conclus
merscov
rbd
nplisa
show
high
consist
ppnt
rtpcr
rbdlisa
show
highest
consist
ppnt
tabl
mer
emerg
infecti
diseas
high
fatal
rate
diagnosi
merscov
infect
use
antimerscov
igg
typic
postexposur
epidemiolog
studi
seropreval
investig
although
antimerscov
serolog
test
kit
commerci
avail
elisa
ifa
develop
euroimmun
germani
perform
especi
sensit
screen
test
kit
need
optim
studi
report
variou
novel
merscov
recombin
antigenbas
lisa
requir
laboratori
speciesspecif
secondari
antibodi
furthermor
lisabas
assay
potenti
use
rapid
specif
sensit
detect
antimerscov
igg
human
anim
tradit
prnt
mn
standard
detect
merscovspecif
antibodi
howev
assay
timeconsum
labori
requir
highlevel
biosafeti
facil
perform
commerci
merscov
elisa
assess
differ
group
shown
sensit
assay
need
improv
show
high
cutoff
valu
optic
densiti
od
ratio
manufactur
instruct
provid
higher
breakpoint
elisa
igg
warrant
specif
borderlin
od
ratio
cutoff
posit
lisa
character
rapid
prepar
ultrasensit
highthroughput
simpl
oper
cell
lysat
directli
use
detect
assay
avoid
purif
postexpress
modif
current
studi
develop
lisa
detect
antimerscov
igg
human
anim
sera
base
novel
ultrasensit
nluc
approach
compar
lisa
commerci
avail
elisa
kit
use
panel
antimerscov
igg
sera
data
indic
sever
lisa
rbd
nplisa
highli
correl
sensit
least
elisa
detect
antimerscov
igg
patient
sampl
also
confirm
rbd
nplisa
abl
specif
recogn
antimerscov
igg
without
crossreactiondi
sampl
deriv
hcov
infect
patient
recent
alagaili
et
al
okba
et
al
report
luciferas
immunoprecipit
system
lip
detect
merscov
antibodi
improv
sensit
specif
compar
lip
lisa
need
preincub
rucantigen
sampl
transfer
mixtur
special
filter
plate
contain
protein
ag
bead
moreov
lisa
need
special
plate
washer
vacuum
captur
antigenantibodybead
complex
lisa
system
nluc
replac
renilla
luciferas
use
lip
nluc
shown
gener
glowtyp
luminesc
signal
halflif
h
greater
activ
renilla
luciferas
also
brighter
firefli
luciferas
lastli
easi
construct
fusion
protein
base
nluc
enzym
full
length
amino
acid
make
excel
report
protein
cov
structur
protein
especi
np
protein
play
import
role
cov
infect
detect
addit
np
probabl
abund
antigen
cov
infect
antibodi
np
use
serolog
diagnost
biomark
optim
antigen
antimerscov
igg
detect
construct
variou
nluc
fusion
protein
base
merscov
np
protein
fragment
protein
result
show
rbd
nplisa
sensit
ntdand
detect
antimerscov
igg
moreov
roc
analysi
show
rbdlisa
superior
nplisa
regard
sensit
specif
detect
antimerscov
igg
serum
sampl
merscov
zoonot
diseas
caus
global
public
health
concern
dromedari
camel
bat
anim
potenti
involv
merscov
transmiss
antibodi
merscov
domest
livestock
includ
dromedari
camel
middleeast
africa
investig
use
ppnt
mn
ifa
assay
merscov
igg
seroposit
gradual
increas
dromedari
calv
middl
east
increas
age
base
current
sever
knowledg
gap
regard
zoonot
origin
animalhuman
interfac
merscov
infect
due
limit
tool
resourc
import
establish
platform
screen
antimerscov
igg
among
differ
speci
endem
area
conduct
traceabl
investig
anim
epidem
foci
theoret
sampl
vector
mite
mosquito
well
anim
includ
bat
mice
camel
monkey
could
detect
lisa
howev
may
detect
use
typic
elisa
due
lack
suitabl
enzymelabel
secondari
antibodi
studi
commerci
elisa
detect
posit
sera
sampl
camel
monkey
mice
howev
posit
sampl
success
detect
sever
lisa
establish
studi
prove
applic
reliabl
lisa
addit
antimerscov
igg
detect
lisa
demonstr
strong
correl
ppnt
rtpcr
sever
anim
host
includ
camel
mice
monkey
furthermor
rbdlisa
sensit
lisa
develop
studi
conclus
develop
sever
novel
lisa
detect
antimerscov
igg
human
anim
assay
potenti
use
largescal
screen
antimerscov
igg
studi
serolog
epidemiolog
merscov
infect
among
speci
